Scanned Document - ????? ??????????????? ??????????
????????? «?????. ?????. ???????». (????? ???????? ???). ????????? ??. ???????????? ??????????? ? ????? ?????? ?????? ??????????????? ??????????? ???????.
&.? - ????? ?86????????? «?????. ?????. ???????» - ???????? ????????????. ?????????? ? ?????????? «???? ????????» (?????? ?????. ??, 1-11 ??????. ???????? ???????????? ... Développons en Java v2.40 - Jean-Michel DOUDOUX... .............19. 1.4.6. Java 1.2 (nom de code Playground)............................................................................................ Programming in Java - DDR Group of CollegesBuilding a new library was not part of the common experience of program- mers, and indeed large-scale re-use of code was the exception rather than the rule. Programmation Java : cours 2 - Cedric-CnamCe code Java ne compile pas : missing return value! Il aurait du compiler et il compile en C++5. Bjarne Stroustrup : Je veux donner un avantage aux bons. JavaScript in 12 easy lessons - Nik LeverIn this book I hope to get you up to speed with writing. JavaScript code. Writing code is great fun and the more you practice the better you'll. Développons en Java v 2.30 - Jean-Michel DOUDOUX... .............16. 1.4.5. Java 1.2 (nom de code Playground)............................................................................................ CM ? X / XA SERIESTermes manquants : ???????????? ???????????????????????????????? ... ??????? 200/100V??? 100V??????????????? ... ????????????? ????? ?? ????» ? 2020 - ???????????, ????? ???, ????????, ??????? ??? (???????? ???????? ???????? ???????? ? 147 ????????) ? ????-????? ???????? (28 ????????), ???????? ??? ???? ??? ... ?????????? ????????? ???????????? ???????? ? ??????? ...??????, ??????? ??????, ?????????? ????, ?????, ???????, ????????, ????????????? ? ???????????? ???? ? ???????? ?????????. Page 13. 13 d ... Egg drop syndrome 1976: host range, prevalence and prevention1Emergency administra- tion of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in.